AdaptHealth Corp. Announces Third Quarter 2026 Results
Business Wire•03/11/2026•07:00 ET
0
Key Highlights
- ➤Q3 net revenue $745.6 million, up 10.9% year over year
- ➤Net loss attributable to AdaptHealth reached $168.2 million after a $184.8 million goodwill write-down
- ➤Diabetes Health sale for $235.0 million cash remains on track for early 2027 closing
- ➤Fiscal 2026 revenue guidance raised to $2.88 billion-$2.90 billion from $2.85 billion-$2.89 billion
- ➤Fiscal 2026 free cash flow guidance cut to $50 million-$75 million from $80 million-$120 million
Expert Statements
Suzanne Foster, Chief Executive Officer of AdaptHealth Corp.
“In the third quarter, we delivered strong organic revenue growth and exceeded our guidance for revenue, Adjusted EBITDA and free cash flow. Our capitated partnership made a positive contribution to enterprise Adjusted EBITDA, driven by a tighter labor model and lower costs to serve. We also continue to move toward closing the sale of our Diabetes Health business, bringing us closer to a more focused portfolio built around Sleep Health, Respiratory Health and Wellness-at-Home. The business is stabilizing as we work through a period of transformation, and we look forward to carrying that momentum into 2027.”
AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today financial results for the third quarter ended September 30, 2026.
* Made solid progress in the second full quarter of the Company’s exclusive capitated agreement with a large national integrated delivery network, with utilization lower than peak levels and reduced labor costs driving a sequential improvement in contract profitability.
Get started
Create a free account to read the full story.